NewsMedicineNew
FDA comment period on generative AI medical devices closes; hospital group asks for clearer risk rules
Public comments on the FDA's discussion paper about regulating generative AI medical devices closed on 19 October, with hospitals asking for clearer risk and labeling rules; the paper is not guidance and binds no one.
Evidence: 5 sources · 3 official records · 2 independent reports · 3 open questions